Popular Articles

Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
Methuselah Foundation has identified Organovo, Inc. as a leader in the extraordinary science of bio-printing. The US Department of Health and Human Services predicts: "Within 20 years regenerative medicine will be the standard of care for replacing all tissue/organ systems in the body." Organovo, with the support of Methuselah Foundation, is applying its breakthrough organ printing technologies to make that prediction a reality.

Wave Medical-Clinical Decision Support Now In Hand And Just A Touch Away
Health professionals need to look no further than their iPhone to support them at the point of care. Wave Medical, who provides clinical decision support applications to general practitioners, nurses, emergency doctors and medical students has recently expanded its mobile platform offering to include the iPhone™ and iPod® Touch. Now all healthcare professionals can easily access any of Wave Medical"s specialty-focused clinical decision support applications through iPhone"s innovative platform.
News of the day
What Is Allergic Conjunctivitis? What Causes Allergic Conjunctivitis?
Most people get allergic conjunctivitis when their eyes come into contact with an allergen - a substance which makes the body"s immune system overreact. The eye becomes sore, inflamed and sometimes painful. Symptoms occur because the overreacting immune system makes the body release histamine and other active substances by mast cells - these cause dilation of blood vessels (blood vessels expand, widen), which irritates the nerve endings and causes increased secretion of tears.
Public Health

Mac Researchers Find "surprising Link" Leads Towards A New Antibiotic

As the best drugs become increasingly resistant to superbugs, McMaster University researchers have discovered a completely different way of looking for a new antibiotic. In a paper to be published published Friday, May 29 in the journal Chemistry and Biology, with colleagues in Germany and Wilfrid Laurier University, they report on work with the bacteria Staphylococcus aureus bacteria, the leading cause of infections in hospitals and the second most common community-acquired infection. Fewer and fewer antibiotics are effective against this bacteria. Cell wall-active antibiotics, such as penicillin, kill bacteria by blocking production of the cell wall. The researchers provide new evidence for genetic connections among three processes in the cell wall - teichoic acid, peptidoglycan and poly-isoprenoid synthesis. "Never before has such a profound link been drawn between these biosynthetic pathways supported by genetic, computational and biochemical evidence," they said in their paper. "We found a connection that perhaps no one expected in the way the cell wall synthesis is wired," said lead author Eric Brown, professor and chair of the department of biochemistry and biomedical sciences in the Michael G. DeGroote School of Medicine. "We found they are inextricably linked in their genetics and biochemistry," he said. "Along the way in this study, we have built a system that is ripe for being exploited as a way to search for small molecule drugs that would target these processes." Potentially, he said, this may lead to the development of a new antibiotic. Brown said the current arsenal of antibiotics was developed during the golden age of antibiotic drug discovery from 1930 to 1960, and then development stopped. Research began again in earnest, he said, when troublesome strains of hospital and community-acquired infections began to emerge, such as MRSA (methicillin-resistant Staphylococcus aureus). "Since the 1960s, drug companies have for, the most part, been tweaking existing molecules, such as building better penicillin with minor changes to the original scaffold. But, you are not very far away from resistance when all you do is a little tweak." The discovery of a "surprising link" between the three processes involved in cell wall synthesis lets researchers build a method of looking for molecules that will disturb the balance between them. "It offers a completely different way of looking for a new antibiotic that would be active against the cell wall," Brown said. McMaster University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):